March 8, 2024

New Winship Invest$ pilot projects highlight innovation and collaboration

Photo of New Winship Invest$ pilot projects highlight innovation and collaboration
Nine teams of investigators will receive a total of $450,000 in funding for new cancer research projects through Winship Invest$, a peer-reviewed program designed to fund novel, innovative cancer research at Winship Cancer Institute of Emory University.

Winship Invest$ has two funding cycles every year and solicits proposals in strategic research domains. The most recent call for proposals focused on projects related to Winship’s four research programs, promoting cancer health equity, breast cancer and new cancer-focused biomedical engineering collaborations. Awards this cycle are supported by philanthropic contributions, the Glenn Family Breast Center, the Wallace H. Coulter Department of Biomedical Engineering as well as developmental funds from Winship's Cancer Center Support Grant (P30CA138292) awarded by the National Cancer Institute.

This cycle's Winship Invest$ pilot grant projects are below.

sFgl2-Directed Immunotherapy to Improve Anti-Tumor Immunity in Melanoma

  • Mandy Ford, PhD
    Professor, Department of Surgery
    Emory University School of Medicine
    Member, Cancer Immunology Research Program
    Winship Cancer Institute of Emory University

Alleviating Disparities in African American Breast Cancer Outcomes through Multi-Modal AI Models Leveraging Radiology Data and Sociodemographic Determinants of Health

  • Judy Wawira Gichoya, MD, MS
    Associate professor, Department of Radiology and Imaging Sciences
    Emory University School of Medicine
    Member, Cancer Prevention and Control Research Program
    Winship Cancer Institute of Emory University

Epigenetic Metabolites as Mediators of Radiation-Resistant Breast Cancer

  • Karmella Haynes, PhD
    Assistant professor, Wallace H. Coulter Department of Biomedical Engineering
    Georgia Institute of Technology and Emory University
    Member, Cell and Molecular Biology Research Program
    Winship Cancer Institute of Emory University
  • Melissa Kemp, PhD
    Carol Ann and David D. Flanagan Professor, Wallace H. Coulter Department of Biomedical Engineering
    Georgia Institute of Technology and Emory University
    Member, Cell and Molecular Biology Research Program
    Winship Cancer Institute of Emory University

Metabolic Drivers of Early-Stage Epigenetic Reprogramming in Environmental Exposure Induced Lung Tumor Initiation

  • Xin Hu, PhD
    Assistant professor, Department of Environmental Health
    Rollins School of Public Health, Emory University
    Member, Cancer Prevention and Control Research Program
    Winship Cancer Institute of Emory University

Drug the ‘Undruggable’ Tumor Suppressor SMAD4 Using Novel Covalent Molecular Glue

  • Xiulei Mo, PhD
    Assistant professor, Department of Pharmacology and Chemical Biology
    Emory University School of Medicine
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University

Prevention of Paclitaxel-Induced Peripheral Neuropathy with Cryotherapy with or without Cilostazol

  • Susan Modesitt, MD, FACOG, FACS
    Director, Division of Gynecologic Oncology, Department of Gynecology and Obstetrics
    Leach Hendee Professor
    Emory University School of Medicine
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University
  • Sarah Dilley, MD, MPH, FACOG
    Assistant professor, Department of Gynecology and Obstetrics
    Emory University School of Medicine
    Member, Cancer Prevention and Control Research Program
    Winship Cancer Institute of Emory University

Combination External Radiation and 177Lu-DOTATATE to Rescue Progression in Large Gastrointestinal Neuroendocrine Tumors: A Single Arm Phase 2 Clinical Trial

  • Pretesh Patel, MD
    Associate professor, Department of Radiation Oncology
    Emory University School of Medicine
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University
  • Olumide Gbolahan, MD
    Assistant professor, Department of Hematology and Medical Oncology
    Emory University School of Medicine
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University

Mechanisms of Enhanced TCR Signaling by Statin Drugs in Preclinical Models of Head and Neck Cancer

  • Nicole Schmitt, MD, FACS
    Associate professor, Department of Otolaryngology
    Emory University School of Medicine
    Co-director for Translational Research, Head and Neck Program
    Winship Cancer Institute of Emory University
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University
  • Cheng Zhu, PhD, MS
    J. Erskine Love Jr. Endowed Chair in Engineering and Regents’ Professor
    Wallace H. Coulter Department of Biomedical Engineering
    Georgia Institute of Technology and Emory University
    Member, Cell and Molecular Biology Research Program
    Winship Cancer Institute of Emory University

Robotic Bronchoalveolar Lavage (RoboBAL) to Enhance Microbe Detection and Decrease Mortality in Pediatric Oncology Patients

  • Kirsten Williams, MD
    Associate professor, Department of Pediatrics
    Emory University School of Medicine
    Member, Cancer Immunology Research Program
    Winship Cancer Institute of Emory University
  • Jaydev Desai, PhD, MA
    Professor and BME Distinguished Faculty Fellow
    Wallace H. Coulter Department of Biomedical Engineering
    Georgia Institute of Technology and Emory University
    Member, Discovery and Developmental Therapeutics Research Program
    Winship Cancer Institute of Emory University

 

 

 

Cascade Link  TOP